Oric Pharmaceuticals, Inc. — Director's Dealing 2025

Oct 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2025-10-03

Reporting Person: Heyman Richard A. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-03	Common Stock	M	31353	$1.60	Acquired	43853	Direct
2025-10-03	Common Stock	M	1447	$3.75	Acquired	45300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-10-03	Stock Option (right to buy)	$1.60	M	13228	Disposed	2028-02-28	Common Stock (13228)	Direct
2025-10-03	Stock Option (right to buy)	$1.60	M	18125	Disposed	2028-06-28	Common Stock (18125)	Direct
2025-10-03	Stock Option (right to buy)	$3.75	M	1447	Disposed	2032-06-16	Common Stock (1447)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	216272	Indirect

Footnotes

F1: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

F2: The shares subject to the option are fully vested and immediately exercisable.